These findings provide new insights into how polyamine metabolism, particularly involving extracellular PUT, impairs the anti-tumor activity of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells, potentially contribut ing to CRC progression. The gene discussed is CXCR6; the disease is neoplasm.